Zenith Capital (Zenith Capital) Inventory Turnover : 0.00 (As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Zenith Capital's Cost of Goods Sold for the three months ended in . 20 was $0.00 Mil. Zenith Capital's Average Total Inventories for the quarter that ended in . 20 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zenith Capital Inventory Turnover Historical Data

The historical data trend for Zenith Capital's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Capital Inventory Turnover Chart

Zenith Capital Annual Data

Trend

Inventory Turnover

Zenith Capital Quarterly Data

Inventory Turnover

Zenith Capital Inventory Turnover Calculation

Zenith Capital's Inventory Turnover for the fiscal year that ended in . 20 is calculated as

	Inventory Turnover (A: . 20 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: . 20 )	/ (	(Total Inventories (A: . 20 )	+	Total Inventories (A: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Zenith Capital's Inventory Turnover for the quarter that ended in . 20 is calculated as

	Inventory Turnover (Q: . 20 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: . 20 )	/ (	(Total Inventories (Q: . 20 )	+	Total Inventories (Q: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Zenith Capital (OTCPK:ZHCLF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zenith Capital's Days Inventory for the three months ended in . 20 is calculated as:

Days Inventory	=	Average Total Inventories (Q: . 20 )	/	Cost of Goods Sold (Q: . 20 )	*	Days in Period
	=	0	/		*	365 / 4
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zenith Capital's Inventory to Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: . 20 )	/	Revenue (Q: . 20 )
	=	0	/
	=

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Zenith Capital Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Zenith Capital's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenith Capital (Zenith Capital) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corp (OTCPK:ZHCLF) » Definitions » Inventory Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

300, 4820 RIchard Road SW, Calgary, AB, CAN, T3E 6L1

Website

Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.

Zenith Capital (Zenith Capital) Headlines

No Headlines